World Non-opioid Discomfort Patch Markets, 2021-2027: Market place to Reach $4.7 Billion – Lidocaine Patches to Account for $1.3 Billion – ResearchAndMarkets.com
3 min readDUBLIN–(Company WIRE)–The “Non-opioid Discomfort Patch – Global Sector Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s supplying.
World wide Non-opioid Soreness Patch Current market to Arrive at $4.7 Billion by 2027
Amid the COVID-19 disaster, the global sector for Non-opioid Discomfort Patch approximated at US$4.1 Billion in the yr 2020, is projected to get to a revised dimension of US$4.7 Billion by 2027, increasing at a CAGR of 2% about the analysis period of time 2020-2027.
Lidocaine Patches, one of the segments analyzed in the report, is projected to document a 2.3% CAGR and achieve US$1.3 Billion by the end of the assessment period of time. After an early examination of the business implications of the pandemic and its induced economic disaster, development in the Diclofenac Patches segment is readjusted to a revised 1.7% CAGR for the upcoming 7-yr interval.
The U.S. Market place is Estimated at $1.1 Billion, Even though China is Forecast to Increase at 3.9% CAGR
The Non-opioid Ache Patch current market in the U.S. is believed at US$1.1 Billion in the 12 months 2020. China, the world`s next most significant financial system, is forecast to access a projected market sizing of US$913 Million by the year 2027 trailing a CAGR of 3.9% above the evaluation interval 2020 to 2027. Among the the other noteworthy geographic markets are Japan and Canada, each forecast to develop at .3% and 1.4% respectively over the 2020-2027 interval. Within just Europe, Germany is forecast to grow at somewhere around .8% CAGR.
Methyl Salicylate Patches Section to History 2.4% CAGR
In the global Methyl Salicylate Patches segment, United states, Canada, Japan, China and Europe will push the 2% CAGR estimated for this segment. These regional markets accounting for a combined market dimensions of US$462.8 Million in the calendar year 2020 will achieve a projected dimension of US$531.7 Million by the near of the analysis interval.
China will continue to be among the speediest developing in this cluster of regional marketplaces. Led by countries this kind of as Australia, India, and South Korea, the market in Asia-Pacific is forecast to arrive at US$629.6 Million by the yr 2027, though Latin The united states will grow at a 3.2% CAGR by means of the evaluation period.
Vital Subjects Coated:
I. METHODOLOGY
II. Executive SUMMARY
1. Sector OVERVIEW
- Influencer Industry Insights
- Entire world Market Trajectories
- Impact of Covid-19 and a Looming World wide Recession
2. Aim ON Pick Gamers (Full 42 Highlighted):
- Acorda Therapeutics, Inc.
- Allergan PLC
- Endo Prescription drugs, Inc.
- GlaxoSmithKline PLC
- Hisamitsu Pharmaceutical Co., Inc.
- IBSA Institut Biochimique SA
- Mylan NV
- Pfizer, Inc.
- TEH SENG Pharmaceutical Mfg. Co., Ltd.
- Teikoku Seiyaku Co. Ltd.
3. Marketplace Traits & Motorists
4. Global Current market Perspective
III. Market place Analysis
- United States
- Canada
- Japan
- China
- Europe
- France
- Germany
- Italy
- United Kingdom
- Spain
- Russia
- Rest Of Europe
- Asia-Pacific
- Australia
- India
- South Korea
- Relaxation Of Asia-Pacific
- Latin The us
- Argentina
- Brazil
- Mexico
- Rest Of Latin America
- Center East
- Iran
- Israel
- Saudi Arabia
- United Arab Emirates
- Rest Of Center East
- Africa
IV. Level of competition
- Total Organizations Profiled: 42
For far more data about this report check out https://www.researchandmarkets.com/r/g7g08